Government-Backed Funding Initiatives Help Spur Antibiotic Research
Bloomberg: There’s Big Money Again in Saving Humanity With Antibiotics
“…With the planet on the brink of losing its miracle cures for bacterial diseases, research incentives from governments are spurring drugmakers to renew efforts to fight antimicrobial resistance and replenish the arsenal of infection-fighting drugs. Giants such as Roche Holding AG and Merck & Co. are stepping up their efforts in the field while a host of startups seek partners to help market new products…” (Gale, 6/30).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.